Allergan's most recent trend suggests a bullish bias. One trading opportunity on Allergan is a Bull Put Spread using a strike $170.00 short put and a strike $165.00 long put offers a potential 28.21% return on risk over the next 24 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $170.00 by expiration. The full premium credit of $1.10 would be kept by the premium seller. The risk of $3.90 would be incurred if the stock dropped below the $165.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Allergan is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Allergan is bullish.
The RSI indicator is above 80 which suggests that the stock is in overbought territory.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Allergan
Developments for Allergan in June
Fri, 22 Jun 2018 11:30:19 +0000
Allergan (AGN) is a specialty pharmaceutical company that develops various products through internal programs and in collaboration with other companies.
Allergan Promotes Male Botox Users With Big Campaign
Thu, 21 Jun 2018 21:15:03 +0000
Bloomberg's Drew Armstrong reports on the trend that's sweeping the medical aesthetics industry as the distributors of Botox, Dysport and Xeomin step up their efforts to sell cosmetic drugs to men. He …
Allergan’s International Business Segment
Thu, 21 Jun 2018 14:30:50 +0000
Allergan’s (AGN) International Business segment includes revenue from both its Specialized Therapeutics portfolio and its General Medicines portfolio from outside the US markets.
Allergan’s US General Medicines Segment
Thu, 21 Jun 2018 13:00:41 +0000
Allergan’s (AGN) US General Medicines segment includes women’s health products, central nervous system products, anti-infective products, gastrointestinal products, and diversified brands.
Allergan’s US Specialized Therapeutics Segment
Thu, 21 Jun 2018 11:32:03 +0000
As discussed earlier, Allergan’s (AGN) US Specialized Therapeutics segment includes revenue from the US sales of specialized products, including eye care products, medical esthetics products, dermatology products, neuroscience products, and urology products.
Also on Market Tamer…
Follow Us on Facebook